Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism GRIN2C modulators(glutamate ionotropic receptor NMDA type subunit 2C modulators), GRIN2D modulators(glutamate ionotropic receptor NMDA type subunit 2D modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nervous System Diseases | Preclinical | US | 11 Aug 2023 |